Chest
-
Late Breaking AbstractsSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: Within 2 weeks in Nov 2013, there were 8 pediatric cases of complicated pneumonia admitted to 6 pediatric ICU in Hong Kong, resulting in 2 deaths associated with hemolytic uremic syndrome. This outbreak led to this description study of the changing epidemiology of complicated pneumonia and associated hemolytic uremic syndrome in children. ⋯ The following authors have nothing to disclose: Gary Wong, Ting Leung, Chante NgNo Product/Research Disclosure Information.
-
Critical Care Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Fever, hypoxia and diffuse pulmonary infiltrates are almost always considered an infectious process. However in an acute presentation, with no identifiable organism or etiology, suspicion for cocaine-induced pulmonary syndrome (crack lung) should be considered. ⋯ The following authors have nothing to disclose: Ma. Theresa Bautista, Ramakant sharma, Ernest DiNinoNo Product/Research Disclosure Information.
-
Respiratory Infections PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Vancomycin is standard of care for the treatment of methicillin-resistant Staphylococcus aureus infection (MRSA). Conventional dosing strategies are intermittent dosing with assessment of therapeutic level. First trough level is obtained before the 4th dose. It often results in readjusting dose and frequency of vancomycin to obtain adequate levels. As the mortality rate for MRSA bacteremia remains high 23.4%, no study has looked at continuous infusion vancomycin (CIV) since the IDSA guidelines in 2009 changing therapeutic level interpretation. We conducted a retrospective review at our academic center to review steady state levels, complications and morbidity. ⋯ The following authors have nothing to disclose: Syed Masood, Christopher Droege, Renee Hebbeler-ClarkNo Product/Research Disclosure Information.
-
Telemedicine PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To determine if an early assisted discharge program for chronic obstructive pulmonary disease (COPD) exacerbations, with telemonitoring and telephone control, is equally effective and more efficient in terms of use of health care resources, that a home care provided by hospital department respiratory ⋯ The following authors have nothing to disclose: Patricia Mínguez, Beatriz Cadavid, Carmen Mata, Rosa Malo, Miriam Aguilar, Manuel Valle, Andrea Trisan, Antolín Lopez, Mario Pascual, Juan Fragua, Piedad UssettiNo Product/Research Disclosure Information.
-
Cardiovascular Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Atrio-esophageal fistula is a fatal complication of radiofrequency ablation, which is associated with 80% mortality rate. Incidence rate for atrio-esophageal fistula formation is reported to be less than 1%. Dissemination of the organisms from the gut into the vasculature is the major cause of mortality. Hence, early diagnosis and immediate surgical intervention is necessary. Here we present a case of atrio-esophageal fistula occurred as a complication of radiofrequency ablation, complicated with sepsis and embolic stroke. ⋯ Given the associated poor prognosis, prompt recognition and emergent intervention are mandatory to decrease the mortality.Reference #1: Dagres N, Hindricks G, Kottkamp H, et al. Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern? J Cardiovasc Electrophysiol 2009; 20:1014-Reference #2: Cappato R, Calkins H, Chen SA, et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol 2009; 53:1798-803.Reference #3: Damian Sanchez-Quintana, Jose Angel Cabrera, Vicente Climent. Anatomic Relations Between The Esophagus and Left Atrium and Relevance for Ablation of Atrial Fibrillation.Circulation. 8/29/2005DISCLOSURE: The following authors have nothing to disclose: Sravanthi NandavaramNo Product/Research Disclosure Information.